A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants

Table 1 The routine immunization schedule recommended in the UK during the study period

Vaccine	Trade name and manufacturer	Recommended age at vaccination (months)
DTaP₃-IPV-Hib	Infanrix-IPV-Hib, GSK	2, 3, 4
Meningococcal serogroup B	Bexsero, GSK	2, 4, 12
13-valent pneumococcal conjugate	Prevenar13, Pfizer	2, 4, 12
Oral live attenuated rotavirus	Rotarix, GSK	2, 3
Meningococcal serogroup C conjugate	NeisVac-C, GSK	3
Hib-MenC	Menitorix, GSK	12
Measles-mumps-rubella (MMR)	Priorix, Sanofi Pasteur	12

Abbreviations: DTaP₃-IPV diphtheria, tetanus, acellular pertussis (three pertussis antigens, 25 μg each of pertussis toxoid and filamentous haemagglutinin and 8 μg of pertactin), inactivated poliovirus, Haemophilus influenzae type B, IPV inactivated poliovirus, Hib Haemophilus influenzae type b, MenC meningococcal serogroup C, GSK GlaxoSmithKleine

ISSN: 1741-7015